It is my opinion that credible critiques from Dr J and Dr Seeth among others were the impetuses of the FDA notice. They are peers and their criticism stings. Furthermore an agency that completely failed the US public on OxyContin, has surely heard worse than what CytoDyn’s shareholders say. But I am very much with you, telling any US cit how they should interface with their government is a nonstarter. I hope that the cc will not devolve into this topic dominating the discussion.
I want to know about the Philippines 28, any orders that have come forward in the Philippines and what’s the state of play with Leronlimab in the UK, Canada, But most importantly, has CYDY reached out to the Albert Einstein Institute and MacLeod and Chiral. What is the reaction to the FDA trash statement and are we still on track with the new trials.